Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration

To study retinal pigment epithelium (RPE) tears after off-label intravitreal bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA) injection for neovascular age-related macular degeneration. Eyes with a vascularized pigment epithelial detachment (PED) that developed an RPE tear were compar...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Retina (Philadelphia, Pa.) Ročník 27; číslo 5; s. 541
Hlavní autoři:	Chan, Clement K, Meyer, Carsten H, Gross, Jeffrey G, Abraham, Prema, Nuthi, Asha S D, Kokame, Gregg T, Lin, Steven G, Rauser, Michael E, Kaiser, Peter K
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.06.2007
Témata:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - adverse effects Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized Bevacizumab Choroidal Neovascularization - drug therapy Female Fluorescein Angiography Humans Injections Macular Degeneration - drug therapy Male Pigment Epithelium of Eye - drug effects Pigment Epithelium of Eye - pathology Retinal Detachment - chemically induced Retinal Detachment - diagnosis Retinal Perforations - chemically induced Retinal Perforations - diagnosis Retrospective Studies Tomography, Optical Coherence Vascular Endothelial Growth Factor A - antagonists & inhibitors Vitreous Body
ISSN:	0275-004X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!